Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: VSC007
MIFTS: 68

Vascular Disease

Categories: Blood diseases, Cardiovascular diseases, Gastrointestinal diseases, Mental diseases, Neuronal diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Vascular Disease

About this section

MalaCards integrated aliases for Vascular Disease:

Name: Vascular Disease 12 15
Vascular Diseases 55 43 44 73
Aneurysm 44 63 73
Spinal Cord Vascular Diseases 44 73
Spinal Cord Ischemia 44 73
Vascular Tissue Disease 12
Vascular Anomaly 55

Classifications:

MalaCards categories:
Anatomical: Mental diseases Gastrointestinal diseases Cardiovascular diseases Neuronal diseases Blood diseases
See all MalaCards categories (disease lists)
ICD10: 33


External Ids:

Disease Ontology 12 DOID:178
ICD9CM 35 442.9
SNOMED-CT 68 27550009 85659009
Sources

Summaries for Vascular Disease

About this section
NINDS : 54 A cerebral aneurysm is a weak or thin spot on a blood vessel in the brain that balloons out and fills with blood.  A cerebral aneurysm can press on a nerve or surrounding tissue in the brain, and also leak or burst, which lets blood spill into surrounding tissues (called a hemorrhage). Cerebral aneurysms can occur at any age, although they are more common in adults than in children and are more common in women than in men. These aneurysms can occur anywhere in the brain. Some small aneurysms may not show signs and are usually detected during imaging tests for other medical conditions. The signs and symptoms of an unruptured cerebral aneurysm will partly depend on its size and rate of growth. A larger aneurysm that is steadily growing may produce symptoms such as numbness, pain above and behind the eye, and paralysis on one side of the face. Immediately after an aneurysm ruptures, an individual may experience such symptoms as a sudden and unusually severe headache, nausea, vision impairment, vomiting, and loss of consciousness.

MalaCards based summary : Vascular Disease, also known as vascular diseases, is related to peripheral vascular disease and hepatic vascular disease, and has symptoms including angina pectoris, edema and chest pain. An important gene associated with Vascular Disease is MIR145 (MicroRNA 145), and among its related pathways/superpathways are Fluid shear stress and atherosclerosis and Selenium Micronutrient Network. The drugs Testosterone enanthate and Methyltestosterone have been mentioned in the context of this disorder. Affiliated tissues include heart, endothelial and brain, and related phenotypes are cardiovascular system and digestive/alimentary

Disease Ontology : 12 A cardiovascular system disease that primarily affects the blood vessels which includes the arteries, veins and capillaries that carry blood to and from the heart.

MedlinePlus : 43 The vascular system is the body's network of blood vessels. It includes the arteries, veins and capillaries that carry blood to and from the heart. Problems of the vascular system are common and can be serious. Arteries can become thick and stiff, a problem called atherosclerosis. Blood clots can clog vessels and block blood flow to the heart or brain. Weakened blood vessels can burst, causing bleeding inside the body. You are more likely to have vascular disease as you get older. Other factors that make vascular disease more likely include Family history of vascular or heart diseases Pregnancy Illness or injury Long periods of sitting or standing still Any condition that affects the heart and blood vessels, such as diabetes or high cholesterol Smoking Obesity Losing weight, eating healthy foods, being active and not smoking can help vascular disease. Other treatments include medicines and surgery.

PubMed Health : 63 About aneurysm: An aneurysm (AN-u-rism) is a balloon-like bulge in an artery. Arteries are blood vessels that carry oxygen-rich blood to your body.Arteries have thick walls to withstand normal blood pressure. However, certain medical problems, genetic conditions, and trauma can damage or injure artery walls. The force of blood pushing against the weakened or injured walls can cause an aneurysm.An aneurysm can grow large and rupture (burst) or dissect. A rupture causes dangerous bleeding inside the body. A dissection is a split in one or more layers of the artery wall. The split causes bleeding into and along the layers of the artery wall.Both rupture and dissection often are fatal.

Wikipedia : 76 Vascular disease is a class of diseases of the blood vessels �?? the arteries and veins of the... more...

Sources

Related Diseases for Vascular Disease

About this section

Diseases related to Vascular Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1433)
# Related Disease Score Top Affiliating Genes
1 peripheral vascular disease 34.6 ACE CRP SERPINE1 VEGFA
2 hepatic vascular disease 34.2 EDN1 MTHFR NOS3 SERPINE1
3 retinal vascular disease 34.0 ACE INS MTHFR VEGFA
4 buerger disease 33.2 MTHFR NOS3 SERPINE1
5 arteriosclerosis 32.5 ACE APOE CRP EDN1 ELN INS
6 autosomal dominant polycystic kidney disease 32.5 ACE EDN1 NOS3 VEGFA
7 ischemia 32.3 ACE EDN1 KNG1 NOS3 VEGFA
8 renal artery disease 32.2 ACE NOS3
9 cerebrovascular disease 32.2 ACE APOE CBS CRP INS MMP9
10 arteries, anomalies of 32.0 ACE ACVRL1 APOE CRP EDN1 INS
11 vein disease 31.8 MTHFR SERPINE1 VEGFA
12 arteriovenous malformation 31.7 ACVRL1 MMP9 VEGFA
13 chronic thromboembolic pulmonary hypertension 31.6 CRP EDN1
14 intermittent claudication 31.5 ACE CRP SERPINE1 VEGFA
15 aortic valve disease 1 31.1 ACE CRP ELN
16 diabetes mellitus 31.0 ACE CRP EDN1 INS MIR145 NOS3
17 heart disease 30.8 ACE APOE CBS CRP EDN1 ELN
18 kidney disease 30.8 ACE APOE CRP EDN1 INS NOS3
19 coronary artery anomaly 30.8 ACE CRP EDN1 KNG1 NOS3 SERPINE1
20 hemifacial spasm 30.8 MTHFR NOS3 VEGFA
21 chronic kidney failure 30.7 ACE CRP EDN1 INS MTHFR NOS3
22 coronary stenosis 30.7 ACE APOE CRP SERPINE1
23 aortic disease 30.6 APOE CRP ELN MMP9
24 impotence 30.6 EDN1 KNG1 NOS3
25 ischemic colitis 30.6 MMP9 SERPINE1 VEGFA
26 diabetes mellitus, noninsulin-dependent 30.6 ACE APOE CRP EDN1 INS MIR125A
27 retinal artery occlusion 30.6 ACE MTHFR SERPINE1 VEGFA
28 homocysteinemia 30.6 CBS CRP MTHFR NOS3
29 orthostatic intolerance 30.5 EDN1 ELN NOS3
30 aortic valve disease 2 30.5 ACE CRP ELN
31 pulmonary hypertension 30.5 ACE ACVRL1 EDN1 MIR21 NOS3
32 limb ischemia 30.4 ACE EDN1 NOS3 VEGFA
33 aortic aneurysm, familial abdominal, 1 30.4 ACE APOE CRP ELN MMP9
34 ischemic heart disease 30.4 ACE APOE CRP MTHFR NOS3
35 sleep apnea 30.4 ACE APOE CRP EDN1 INS NOS3
36 coronary heart disease 1 30.4 ACE APOE CRP EDN1 INS MIR145
37 carotid stenosis 30.4 ACE APOE CRP MMP9 MTHFR
38 peripheral artery disease 30.4 ACE CRP NOS3 VEGFA
39 myocardial infarction 30.3 ACE APOE CBS CRP EDN1 INS
40 aortic coarctation 30.3 ACE EDN1 NOS3
41 retinal vein occlusion 30.3 MTHFR SERPINE1 VEGFA
42 renal hypertension 30.2 ACE EDN1 KNG1
43 lemierre's syndrome 30.2 CRP KNG1 MTHFR SERPINE1
44 atherosclerosis susceptibility 30.2 APOE CRP INS NOS3 SERPINE1
45 angina pectoris 30.2 ACE CRP EDN1 NOS3
46 diabetic neuropathy 30.2 ACE INS VEGFA
47 pre-eclampsia 30.1 EDN1 KNG1 MTHFR NOS3 SERPINE1 VEGFA
48 venous insufficiency 30.1 CRP MMP9 SERPINE1
49 portal hypertension 30.1 EDN1 NOS3 VEGFA
50 acute myocardial infarction 30.1 ACE CRP EDN1 MMP9 SERPINE1

Graphical network of the top 20 diseases related to Vascular Disease:



Diseases related to Vascular Disease
Sources

Symptoms & Phenotypes for Vascular Disease

About this section

UMLS symptoms related to Vascular Disease:


angina pectoris, edema, chest pain, flushing, leg cramps, warm skin, vein pain

MGI Mouse Phenotypes related to Vascular Disease:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.96 ACE ACVRL1 APOE CRP EDN1 INS
2 digestive/alimentary MP:0005381 9.7 ACVRL1 APOE EDN1 INS MMP9 NOS3
3 liver/biliary system MP:0005370 9.56 ACE ACVRL1 APOE INS MTHFR NOS3
4 renal/urinary system MP:0005367 9.28 ACE ACVRL1 APOE EDN1 INS MMP9
Sources

Drugs & Therapeutics for Vascular Disease

About this section

PubMedHealth treatment related to Vascular Disease: 63

Aortic aneurysms are treated with medicines and surgery. Small aneurysms that are found early and aren’t causing symptoms may not need treatment. Other aneurysms need to be treated.The goals of treatment may include:Preventing the aneurysm from growingPreventing or reversing damage to other body structuresPreventing or treating a rupture or dissectionAllowing you to continue doing your normal daily activitiesTreatment for an aortic aneurysm is based on its size. Your doctor may recommend routine testing to make sure an aneurysm isn't getting bigger. This method usually is used for aneurysms that are smaller than 5 centimeters (about 2 inches) across.How often you need testing (for example, every few months or every year) is based on the size of the aneurysm and how fast it's growing. The larger it is and the faster it's growing, the more often you may need to be checked.

Drugs for Vascular Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1262)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Testosterone enanthate Approved Phase 4,Phase 2 315-37-7 9416
2
Methyltestosterone Approved Phase 4,Phase 2 58-18-4 6010
3
Testosterone Approved, Investigational Phase 4,Phase 2 58-22-0 6013
4
Testosterone undecanoate Approved, Investigational Phase 4,Phase 2 5949-44-0
5
Ranibizumab Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 347396-82-1 459903
6
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 33069-62-4 36314
7
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-78-2 2244
8
Glucosamine Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 3416-24-8 439213
9
Ramipril Approved Phase 4,Phase 3,Phase 2,Not Applicable 87333-19-5 5362129
10
Ticlopidine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 55142-85-3 5472
11
Clopidogrel Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 113665-84-2, 120202-66-6 60606
12
Simvastatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 79902-63-9 54454
13
Ustekinumab Approved, Investigational Phase 4 815610-63-0
14
Exenatide Approved, Investigational Phase 4,Phase 3 141758-74-9 15991534
15
Metformin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 657-24-9 14219 4091
16
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 51-45-6, 75614-87-8 774
17
Famotidine Approved Phase 4,Phase 2 76824-35-6 3325
18
Esomeprazole Approved, Investigational Phase 4,Phase 1 161796-78-7, 119141-88-7 4594 9579578
19
Enalapril Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 75847-73-3 5362032 40466924
20
Enalaprilat Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 76420-72-9 6917719
21
Povidone Approved Phase 4,Early Phase 1 9003-39-8
22
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
23
Iodine Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable,Early Phase 1 7553-56-2 807
24
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613
25
Teicoplanin Approved, Investigational Phase 4 61036-62-2
26
Chlorhexidine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1 55-56-1 2713 9552079
27
Metronidazole Approved Phase 4,Not Applicable 443-48-1 4173
28
Povidone-iodine Approved Phase 4,Early Phase 1,Not Applicable 25655-41-8
29
Sevelamer Approved Phase 4 52757-95-6
30
Cilostazol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 73963-72-1 2754
31
Ticagrelor Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 274693-27-5 9871419
32
Pravastatin Approved Phase 4,Phase 3,Phase 2,Not Applicable 81093-37-0 54687
33
Esmolol Approved Phase 4 103598-03-4, 81147-92-4 59768
34
Remifentanil Approved Phase 4,Phase 3,Not Applicable 132875-61-7 60815
35
Amlodipine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 88150-42-9 2162
36
Nifedipine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 21829-25-4 4485
37
Ondansetron Approved Phase 4,Phase 2,Phase 3,Not Applicable 99614-02-5 4595
38
Nitric Oxide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 10102-43-9 145068
39
Sevoflurane Approved, Vet_approved Phase 4,Phase 2,Not Applicable 28523-86-6 5206
40
Desflurane Approved Phase 4,Not Applicable 57041-67-5 42113
41
Isoflurane Approved, Vet_approved Phase 4,Not Applicable 26675-46-7 3763
42
Metoprolol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 37350-58-6, 51384-51-1 4171
43
Bisoprolol Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable,Early Phase 1 66722-44-9 2405
44
Telmisartan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 144701-48-4 65999
45
Hydrochlorothiazide Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-93-5 3639
46
Angiotensin II Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 11128-99-7, 68521-88-0, 4474-91-3 172198 65143
47
Amiloride Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2016-88-8, 2609-46-3 16231
48
Nitrendipine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 39562-70-4 4507
49
Captopril Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable,Early Phase 1 62571-86-2 44093
50
Chlorthalidone Approved Phase 4,Phase 3,Phase 2,Not Applicable 77-36-1 2732

Interventional clinical trials:

(show top 50) (show all 10000)
# Name Status NCT ID Phase Drugs
1 Testosterone for Peripheral Vascular Disease Unknown status NCT00504712 Phase 4 Testosterone;0.9% saline
2 Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial) Unknown status NCT02092532 Phase 4 Rescue Intravitreal Aflibercept Injection
3 Intraocular Cytokine in Recurrence of Polypoidal Choroidal Vasculopathy Unknown status NCT02976194 Phase 4 ranibizumab
4 Paclitaxel Eluting Balloon and Conventional Balloon for In-Stent Restenosis of the Superficial Femoral Artery Unknown status NCT01083394 Phase 4
5 Efficacy Study of Stenting, Paclitaxel Eluting Balloon or Atherectomy to Treat Peripheral Artery Disease Unknown status NCT00986752 Phase 4
6 Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part II) (DCLI-II) Unknown status NCT01173094 Phase 4
7 Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part I) Unknown status NCT01171703 Phase 4
8 Comparison of Stent and Prothesis Bypass in Superficial Femoral Artery Unknown status NCT01147419 Phase 4
9 Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy Unknown status NCT01743014 Phase 4 Ramipril;Clopidogrel
10 Living With Statins - Interventional Exercise Study Unknown status NCT02796378 Phase 4 Training+Simvastatin+Q10-placebo;Training+Simvastatin-placebo+Q10-placebo;Training+Simvastatin+Q10
11 Early Warning and Optimization Strategy in Carotid Endarterectomy Unknown status NCT01210937 Phase 4
12 Study Effects of Ginkgo Biloba Extract on Endothelial Cell Function and Genetic Effects on the Response to Ginkgo Biloba Extract in Diabetic Patients With Stable Coronary Artery Disease Unknown status NCT01038050 Phase 4 Ginkgo Biloba Extract (GBE)
13 The Difference of Microparticles in Patients With Psoriasis Vulgaris Who Received Stelara(Ustekinumab) Unknown status NCT02693470 Phase 4 Ustekinumab
14 Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Function Unknown status NCT02584075 Phase 4 Byetta (Exenatide);Glucophage ( Metformin Hydrochloride)
15 Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer Dyspepsia Unknown status NCT00978159 Phase 4 esomeprazole;Famotidine
16 LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients Unknown status NCT02077257 Phase 4 Rosuvastatin
17 Anti-Hypertensive Agent (ACEi) and Heart Function Improvement in Association With Rho Kinase Activity Changes in Human Unknown status NCT01069042 Phase 4 Enalapril
18 The Amputation Surgical Site Infection Trial (ASSIT) Unknown status NCT02018094 Phase 4 Co-amoxiclav;Iodine;Metronidazole;Chlorhexidine;Teicoplanin;Clindamycin
19 Graz Study on the Risk of Atrial Fibrillation Unknown status NCT01461434 Phase 4
20 How Bone is Made in Children Receiving Dialysis Unknown status NCT01799317 Phase 4 Vitamin D2
21 Safety and Efficacy Study of OmniWave Endovascular System to Treat Deep Vein Thrombosis Unknown status NCT00640731 Phase 4
22 Lovaza Mechanisms of Action Unknown status NCT01301794 Phase 4
23 Residual Platelet Activity In Advanced Peripheral Artery Disease Unknown status NCT01627431 Phase 4 Acetylsalicylic acid;Clopidogrel
24 Platelets Induced Vasodilation, in Vitro and in Vivo Study Unknown status NCT00152646 Phase 4 placebo, aspirine, clopidogrel
25 Paclitaxel Eluting Stent or Exercise for Thigh Atherosclerosis Unknown status NCT02033135 Phase 4
26 Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease Unknown status NCT01653600 Phase 4
27 Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events Unknown status NCT00886574 Phase 4 Cilostazol;Aspirin
28 Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy Unknown status NCT01823185 Phase 4 clopidogrel;Ticagrelor or prasugrel
29 Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic Nephropathy Unknown status NCT01023373 Phase 4 Medical treatment
30 The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris Unknown status NCT01325818 Phase 4 pravastatin, rosuvastatin
31 Effect of Controlled Hypotension on Cerebral Oxygen Saturation Unknown status NCT02967029 Phase 4 Esmolol Hydrochloride;Remifentanil Hydrochloride
32 Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial Stiffness Unknown status NCT02940548 Phase 4 Nifedipine GITS;Amlodipine besylate
33 Reduction in Spinal-induced Hypotension With Ondansetron in Parturients Undergoing Caesarean Section Unknown status NCT02913768 Phase 4 Ondansetron;Normal saline
34 L-arginine Treatment in Mild Hypertension Unknown status NCT02894723 Phase 4
35 Antihypertensive Treatment in Masked Hypertension for Target Organ Protection Unknown status NCT02893358 Phase 4 Allisartan Isoproxil;Placebo
36 Comparison of Volatile Anesthetics on Cerebral Oxygenation During Controlled Hypotension Unknown status NCT02834845 Phase 4 Sevoflurane;Desflurane
37 The Effect of the Timing of Colloid and Crystalloid Infusions on Postspinal Hypotension After Spinal Anesthesia for Caesarian Section Unknown status NCT02680678 Phase 4
38 Effect of Nifedipine GITS in Patients With Mild-to-moderate Primary Hypertension Unknown status NCT02641821 Phase 4 Nifedipine GITS
39 Efficacy and Safety of Arotinolol Hydrochloride on Morning Blood Pressure and Heart Rate Unknown status NCT02612298 Phase 4 Arotinolol Hydrochloride;Metoprolol succinate sustained-release tablet
40 BRAVE Study With Uncontrolled Essential Hypertension (BRAVE Study) Unknown status NCT02398929 Phase 4 Bisoprolol 2.5 mg;Placebo
41 Colloid Preload Versus Colloid Coload During Cesarean Deliveries Unknown status NCT02393196 Phase 4 hydroxyethyl starch (% 6 HES 130/0.4) (Voluven®);hydroxyethyl starch (%6 HES 130/0.4) (Voluven®)
42 Multifactorial Intervention on Cardiovascular Risk Factors in Subjects With Peripheral Arterial Disease Unknown status NCT00144937 Phase 4 Stepwise therapy for dyslipidemia, hypertension and diabetes
43 INTERVENCION Trial Unknown status NCT02373163 Phase 4 Hydrochlorothiazide;Amlodipine;Telmisartan
44 Comparison of Single and Combination Diuretics in Low-Renin Hypertension Unknown status NCT02351973 Phase 4 Hydrochlorthiazide;Amiloride;Hydrochlorthiazide and Amiloride
45 The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy Unknown status NCT02231788 Phase 4 Telminuvo®Tab. 40/2.5mg;Telmitrend®Tab. 80mg
46 Treatment of Hypertension in Tibetan Adult Population Unknown status NCT02217852 Phase 4 Nitrendipine;Hydrochlorothiazide;Captopril,Hydrochlorothiazide;Beijing hypotensive No.0
47 Treatment of HYpertension: Morning Versus Evening Unknown status NCT02214498 Phase 4 Enalapril/hydrochlorothiazide;Placebo
48 The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension Unknown status NCT02156024 Phase 4 Gastrodia and Uncaria Drink
49 Chlorthalidone and HCTZ Impacts on Platelet Activation Unknown status NCT02100462 Phase 4 Chlorthalidone 12.5 mg;Hydrochlorothiazide 25 mg;Aspirin 81 mg
50 The Hypotensive Effect of Metformin in Hypertensive Patients. Unknown status NCT02072382 Phase 4 Metformin;Placebo

Search NIH Clinical Center for Vascular Disease

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: vascular diseases

Sources

Genetic Tests for Vascular Disease

About this section
Sources

Anatomical Context for Vascular Disease

About this section

MalaCards organs/tissues related to Vascular Disease:

41
Heart, Endothelial, Brain, Spinal Cord, Kidney, Testes, Lung
Sources

Publications for Vascular Disease

About this section

Articles related to Vascular Disease:

(show top 50) (show all 3738)
# Title Authors Year
1
A comparative study on the effect of argan oil versus fish oil on risk factors for cardio-vascular disease in high-fat-fed rats. ( 30153577 )
2019
2
Genome-edited MSCs that express GCP-2 and SDF-1α might be a novel therapeutic strategy for the treatment of ischemic vascular disease. ( 30449331 )
2019
3
Suicide right ventricle after lung transplantation for pulmonary vascular disease. ( 29921031 )
2018
4
Determination of hemodynamic risk for vascular disease in planar artery bifurcations. ( 29434229 )
2018
5
Utilization and in-hospital outcomes associated with atherectomy in the treatment of peripheral vascular disease: An observational analysis from the National Inpatient Sample. ( 29466936 )
2018
6
A Nonsurgical Approach to Mesenteric Vascular Disease: Erratum. ( 29864088 )
2018
7
Peripheral vascular disease assessment in the lower limb: a review of current and emerging non-invasive diagnostic methods. ( 29751811 )
2018
8
Long-Term Prognosis of Patients With Transient Ischemic Attack or Stroke and Symptomatic Vascular Disease in Multiple Arterial Beds. ( 29880551 )
2018
9
Correction: The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease. ( 29953560 )
2018
10
Gene polymorphisms of fibronectin rs2289202 and fibrillin 2 rs331069 associate with vascular disease, the TAMRISK study. ( 29399340 )
2018
11
Abstracts from the 11th International Conference on Neonatal and Childhood Pulmonary Vascular Disease, 2018. ( 29897297 )
2018
12
Reversible cerebral vasoconstriction complicating cerebral atherosclerotic vascular disease in Schimke immuno-osseous dysplasia. ( 29978300 )
2018
13
<i>ALU</i>minating the Path of Atherosclerosis Progression: Chaos Theory Suggests a Role for <i>Alu</i> Repeats in the Development of Atherosclerotic Vascular Disease. ( 29895733 )
2018
14
Signalling through Src family kinase isoforms is not redundant in models of thrombo-inflammatory vascular disease. ( 29974666 )
2018
15
Is Pulmonary Vascular Disease reversible with PPAR EL agonists? ( 29432661 )
2018
16
Long-term atherosclerotic vascular disease risk and prognosis in elderly women with abdominal aortic calcification on lateral spine images captured during bone density testing: A prospective study. ( 29443425 )
2018
17
Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease. ( 29947750 )
2018
18
<i>ABCA7</i> and risk of dementia and vascular disease in the Danish population. ( 29376091 )
2018
19
Inadequate Health Literacy in Patients with Arterial Vascular Disease. ( 29891435 )
2018
20
Right Ventricular Base/Apex Ratio in the Assessment of Pediatric Pulmonary Arterial Hypertension - Results from the European Pediatric Pulmonary Vascular Disease Network. ( 29896859 )
2018
21
Nathan Bryan, PhD: Addressing the Root of Vascular Disease With Nitric Oxide. ( 29859509 )
2018
22
Pulmonary hypertension and pulmonary vascular disease: course report. ( 29928464 )
2018
23
Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add? ( 29945212 )
2018
24
Early Pulmonary Vascular Disease in Young Adults Born Preterm. ( 29944842 )
2018
25
Pulmonary Vascular Disease: Hemodynamic Assessment and Treatment Selection-Focus on Group II Pulmonary Hypertension. ( 29417467 )
2018
26
Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. ( 29308539 )
2018
27
Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease. ( 29310800 )
2018
28
Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular disease. ( 29878973 )
2018
29
Association of sleep-disordered breathing with severe chronic vascular disease in patients with type 2 diabetes. ( 29859478 )
2018
30
Identifying Pain and Effects on Quality of Life from Chronic Wounds Secondary to Lower-Extremity Vascular Disease: An Integrative Review. ( 29438151 )
2018
31
Gender Differences in Peripheral Vascular Disease. ( 29628610 )
2018
32
Influence of micro- and macro-vascular disease and Tumor Necrosis Factor Receptor 1 on the level of lower-extremity amputation in patients with type 2 diabetes. ( 29879997 )
2018
33
HRCT findings of collagen vascular disease-related interstitial pneumonia (CVD-IP): a comparative study among individual underlying diseases. ( 29857950 )
2018
34
Comparisons of the Framingham and Pooled Cohort Equation Risk Scores for Detecting Subclinical Vascular Disease in Blacks Versus Whites. ( 29361288 )
2018
35
A Nonsurgical Approach to Mesenteric Vascular Disease. ( 29419563 )
2018
36
Peripheral vascular disease risk in diabetic individuals without coronary heart disease. ( 29801688 )
2018
37
Erectile dysfunction is associated with subclinical carotid vascular disease in young men lacking widely-known risk factors. ( 29442076 )
2018
38
First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension. ( 29348153 )
2018
39
Hospital readmissions in diabetic kidney transplant recipients with peripheral vascular disease. ( 29704405 )
2018
40
Identifying Pain and Effects on Quality of Life from Chronic Wounds Secondary to Lower-Extremity Vascular Disease: An Integrative Review. ( 29438143 )
2018
41
Using Omics to Understand and Treat Pulmonary Vascular Disease. ( 29881726 )
2018
42
Epigenetic Regulation of Vascular Aging and Age-Related Vascular Diseases. ( 30232752 )
2018
43
Main title: pulmonary vascular disease is evident in gene regulation of experimental bronchopulmonary dysplasia. ( 30428746 )
2018
44
Collagen Vascular Diseases: SLE, Dermatomyositis, Scleroderma, and MCTD. ( 30275033 )
2018
45
Is There an Association of Vascular Disease and Atherosclerosis in Children and Adolescents With Obesity and Non-alcoholic Fatty Liver Disease? ( 30505829 )
2018
46
Sex and Gender Differences in Ischemic Heart Disease: Endocrine Vascular Disease Approach (EVA) Study Design. ( 30511337 )
2018
47
Association between Airborne Fine Particulate Matter and Residents' Cardiovascular Diseases, Ischemic Heart Disease and Cerebral Vascular Disease Mortality in Areas with Lighter Air Pollution in China. ( 30177663 )
2018
48
Pulmonary arterial compliance is a useful predictor of pulmonary vascular disease in congenital heart disease. ( 30225809 )
2018
49
Direct correlation between serum homocysteine level and insulin resistance index in patients with subclinical hypothyroidism: Does subclinical hypothyroidism increase the risk of diabetes and cardio vascular disease together? ( 29748035 )
2018
50
Changes in the nitric oxide pathway of the pulmonary vasculature after exposure to hypoxia in swine model of neonatal pulmonary vascular disease. ( 30375198 )
2018